{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:11:00Z","timestamp":1791857460458,"version":"4.3.4"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T00:00:00Z","timestamp":1539129600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI119841"],"award-info":[{"award-number":["R21AI119841"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P20-GM103464"],"award-info":[{"award-number":["P20-GM103464"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54-GM104941"],"award-info":[{"award-number":["U54-GM104941"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012465","name":"Nemours Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012465","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02231","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T04:20:11Z","timestamp":1539145211000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Chimeric Antigen Receptors Based on Low Affinity Mutants of Fc\u03b5RI Re-direct T Cell Specificity to Cells Expressing Membrane IgE"],"prefix":"10.3389","volume":"9","author":[{"given":"Dana E.","family":"Ward","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany L.","family":"Fay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adebomi","family":"Adejuwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,10,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/ni.3829","article-title":"The immunology of the allergy epidemic and the hygiene hypothesis","volume":"18","author":"Lambrecht","year":"2017","journal-title":"Nat Immunol."},{"key":"B2","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.4049\/jimmunol.158.3.1438","article-title":"Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody","volume":"158","author":"MacGlashan","year":"1997","journal-title":"J Immunol."},{"key":"B3","unstructured":"Omalizumab: a recombinant humanized monoclonal IgE-blocking antibody2 ScheinfeldN 15748543Dermatol Online J.112005"},{"key":"B4","unstructured":"Omalizumab: a monoclonal anti-IgE antibody27 BelliveauPP 16369332MedGenMed72005"},{"key":"B5","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJMoa1103849","article-title":"Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia","volume":"365","author":"Porter","year":"2011","journal-title":"N Engl J Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1182\/blood-2011-10-384388","article-title":"B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells","volume":"119","author":"Kochenderfer","year":"2012","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor-modified T cells for acute lymphoid leukemia","volume":"368","author":"Grupp","year":"2013","journal-title":"N Engl J Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1126\/scitranslmed.3005930","article-title":"CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia","volume":"5","author":"Brentjens","year":"2013","journal-title":"Sci Transl Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.1182\/blood-2010-04-281931","article-title":"Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19","volume":"116","author":"Kochenderfer","year":"2010","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1126\/scitranslmed.3002842","article-title":"T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia","volume":"3","author":"Kalos","year":"2011","journal-title":"Sci Transl Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1126\/scitranslmed.3003761","article-title":"Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells","volume":"4","author":"Scholler","year":"2012","journal-title":"Sci Transl Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/ni.2256","article-title":"IgE(+) memory B cells and plasma cells generated through a germinal-center pathway","volume":"13","author":"Talay","year":"2012","journal-title":"Nat Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nri3632","article-title":"The production and regulation of IgE by the immune system","volume":"14","author":"Wu","year":"2014","journal-title":"Nat Rev Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"14449","DOI":"10.1021\/bi00044a023","article-title":"Bent domain structure of recombinant human IgE-Fc in solution by X-ray and neutron scattering in conjunction with an automated curve fitting procedure","volume":"34","author":"Beavil","year":"1995","journal-title":"Biochemistry"},{"key":"B15","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/ni811","article-title":"The crystal structure of IgE Fc reveals an asymmetrically bent conformation","volume":"3","author":"Wan","year":"2002","journal-title":"Nat Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/35018500","article-title":"Structure of the Fc fragment of human IgE bound to its high-affinity receptor Fc epsilonRI alpha","volume":"406","author":"Garman","year":"2000","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1365-2249.2010.04210.x","article-title":"CD23\/FcepsilonRII: molecular multi-tasking","volume":"162","author":"Acharya","year":"2010","journal-title":"Clin Exp Immunol."},{"key":"B18","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4049\/jimmunol.130.1.350","article-title":"Induction of an IgE response in mice by Nippostrongylus brasiliensis: characterization of lymphoid cells with intracytoplasmic or surface IgE","volume":"130","author":"Katona","year":"1983","journal-title":"J Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nri2072","article-title":"New developments in FcepsilonRI regulation, function and inhibition","volume":"7","author":"Kraft","year":"2007","journal-title":"Nat Rev Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"12686","DOI":"10.1073\/pnas.1207278109","article-title":"Crystal structure of IgE bound to its B-cell receptor CD23 reveals a mechanism of reciprocal allosteric inhibition with high affinity receptor FcepsilonRI","volume":"109","author":"Dhaliwal","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"key":"B21","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nri1181","article-title":"The regulation of immunoglobulin E class-switch recombination","volume":"3","author":"Geha","year":"2003","journal-title":"Nat Rev Immunol."},{"key":"B22","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.4049\/jimmunol.148.8.2340","article-title":"Murine follicular dendritic cells and low affinity Fc receptors for IgE (Fc epsilon RII)","volume":"148","author":"Maeda","year":"1992","journal-title":"J Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1097\/CJI.0b013e3180de5d90","article-title":"Redirected activity of human antitumor chimeric immune receptors is governed by antigen and receptor expression levels and affinity of interaction","volume":"30","author":"Turatti","year":"2007","journal-title":"J Immunother."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1172\/JCI40141","article-title":"Antibodies specific for a segment of human membrane IgE deplete IgE-producing B cells in humanized mice","volume":"120","author":"Brightbill","year":"2010","journal-title":"J Clin Invest."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1002\/1521-4141(200111)31:11<3298::AID-IMMU3298>3.0.CO;2-U","article-title":"IgG-dependent activation of human mast cells following up-regulation of FcgammaRI by IFN-gamma","volume":"31","author":"Woolhiser","year":"2001","journal-title":"Eur J Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1093\/nar\/16.8.3584","article-title":"Isolation of the gene coding for the alpha subunit of the human high affinity IgE receptor","volume":"16","author":"Kochan","year":"1988","journal-title":"Nucleic Acids Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1038\/nprot.2007.296","article-title":"Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester","volume":"2","author":"Quah","year":"2007","journal-title":"Nat Protoc."},{"key":"B28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/0471142735.im0738s91","article-title":"Measuring mast cell mediator release","volume":"91","author":"Kuehn","year":"2010","journal-title":"Curr Protoc Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e89357","DOI":"10.1371\/journal.pone.0089357","article-title":"Measuring cytotoxicity by bioluminescence imaging outperforms the standard chromium-51 release assay","volume":"9","author":"Karimi","year":"2014","journal-title":"PLoS ONE"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e11867","DOI":"10.1371\/journal.pone.0011867","article-title":"A simple and sensitive method for measuring tumor-specific T cell cytotoxicity","volume":"5","author":"Fu","year":"2010","journal-title":"PLoS ONE"},{"key":"B31","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1080\/14653240600957586","article-title":"Expression and role of MHC class I-related chain in myeloma cells","volume":"8","author":"Okamoto","year":"2006","journal-title":"Cytotherapy"},{"key":"B32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/intimm\/14.1.39","article-title":"Human CD8 co-receptor is strictly involved in MHC-peptide tetramer-TCR binding and T cell activation","volume":"14","author":"Campanelli","year":"2002","journal-title":"Int Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"6650","DOI":"10.4049\/jimmunol.171.12.6650","article-title":"Anti-CD8 antibodies can inhibit or enhance peptide-MHC class I (pMHCI) multimer binding: this is paralleled by their effects on CTL activation and occurs in the absence of an interaction between pMHCI and CD8 on the cell surface","volume":"171","author":"Wooldridge","year":"2003","journal-title":"J Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"6938","DOI":"10.4049\/jimmunol.0901766","article-title":"The optimal antigen response of chimeric antigen receptors harboring the CD3zeta transmembrane domain is dependent upon incorporation of the receptor into the endogenous TCR\/CD3 complex","volume":"184","author":"Bridgeman","year":"2010","journal-title":"J Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"15579","DOI":"10.1021\/bi9713005","article-title":"Identification of contact residues in the IgE binding site of human FcepsilonRIalpha","volume":"36","author":"Cook","year":"1997","journal-title":"Biochemistry"},{"key":"B36","doi-asserted-by":"publisher","first-page":"13345","DOI":"10.1074\/jbc.274.19.13345","article-title":"Fine structure analysis of interaction of FcepsilonRI with IgE","volume":"274","author":"Hulett","year":"1999","journal-title":"J Biol Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1146\/annurev.immunol.21.120601.141103","article-title":"The biology of IGE and the basis of allergic disease","volume":"21","author":"Gould","year":"2003","journal-title":"Annu Rev Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0022-1759(90)90040-3","article-title":"A bioassay for the measurement of human interleukin-4","volume":"132","author":"Siegel","year":"1990","journal-title":"J Immunol Methods"},{"key":"B39","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1158\/2326-6066.CIR-13-0006","article-title":"T cells expressing chimeric antigen receptors can cause anaphylaxis in humans","volume":"1","author":"Maus","year":"2013","journal-title":"Cancer Immunol Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.immuni.2012.02.009","article-title":"Fluorescent in vivo detection reveals that IgE(+) B cells are restrained by an intrinsic cell fate predisposition","volume":"36","author":"Yang","year":"2012","journal-title":"Immunity"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1084\/jem.20131539","article-title":"The distinctive germinal center phase of IgE+ B lymphocytes limits their contribution to the classical memory response","volume":"210","author":"He","year":"2013","journal-title":"J Exp Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0008-8749(84)90330-7","article-title":"Long-lived IgE- and IgG-secreting cells in rodents manifesting persistent antibody responses","volume":"89","author":"Holt","year":"1984","journal-title":"Cell Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jaci.2009.06.047","article-title":"Induction of long-lived allergen-specific plasma cells by mucosal allergen challenge","volume":"124","author":"Luger","year":"2009","journal-title":"J Allergy Clin Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/S1097-2765(03)00474-X","article-title":"Evidence that structural rearrangements and\/or flexibility during TCR binding can contribute to T cell activation","volume":"12","author":"Krogsgaard","year":"2003","journal-title":"Mol Cell"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1002\/mds.10531","article-title":"Measuring the rate of progression of Parkinson's disease over a 5-year period with beta-CIT SPECT","volume":"18","author":"Pirker","year":"2003","journal-title":"Mov Disord."},{"key":"B46","unstructured":"Effect of chronic endogenous antigen stimulation on CAR T cell persistence and memory formation166 YangY KohlerME FryTJ Blood1302017"},{"key":"B47","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1034\/j.1399-3003.2000.15.11.x","article-title":"Local production and detection of (specific) IgE in nasal B-cells and plasma cells of allergic rhinitis patients","volume":"15","author":"KleinJan","year":"2000","journal-title":"Eur Respir J."},{"key":"B48","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/eji.1830160206","article-title":"Limiting dilution analysis of the B cell compartment in human bone marrow","volume":"16","author":"Hibi","year":"1986","journal-title":"Eur J Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1001\/jamaoncol.2017.0184","article-title":"HER2-specific chimeric antigen receptor-modified virus-specific T cells for progressive glioblastoma: a phase 1 dose-escalation trial","volume":"3","author":"Ahmed","year":"2017","journal-title":"JAMA Oncol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1172\/JCI32103","article-title":"Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates","volume":"118","author":"Berger","year":"2008","journal-title":"J Clin Invest."},{"key":"B51","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/imr.12137","article-title":"A new approach to gene therapy using Sleeping Beauty to genetically modify clinical-grade T cells to target CD19","volume":"257","author":"Singh","year":"2014","journal-title":"Immunol Rev."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1172\/JCI32949","article-title":"Retroviral integration and human gene therapy","volume":"117","author":"Bushman","year":"2007","journal-title":"J Clin Invest."},{"key":"B53","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature21405","article-title":"Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection","volume":"543","author":"Eyquem","year":"2017","journal-title":"Nature"},{"key":"B54","doi-asserted-by":"publisher","first-page":"8572","DOI":"10.1038\/srep08572","article-title":"Site-specific integration in CHO cells mediated by CRISPR\/Cas9 and homology-directed DNA repair pathway","volume":"5","author":"Lee","year":"2015","journal-title":"Sci Rep."},{"key":"B55","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41586-018-0326-5","article-title":"Reprogramming human T cell function and specificity with non-viral genome targeting","volume":"559","author":"Roth","year":"2018","journal-title":"Nature"},{"key":"B56","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1146\/annurev-immunol-051116-052302","article-title":"Synthetic immunology: hacking immune cells to expand their therapeutic capabilities","volume":"35","author":"Roybal","year":"2017","journal-title":"Annu Rev Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1056\/NEJMoa1106152","article-title":"Inducible apoptosis as a safety switch for adoptive cell therapy","volume":"365","author":"Di","year":"2011","journal-title":"N Engl J Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"aab4077","DOI":"10.1126\/science.aab4077","article-title":"Remote control of therapeutic T cells through a small molecule-gated chimeric receptor","volume":"350","author":"Wu","year":"2015","journal-title":"Science"},{"key":"B59","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1398-9995.2007.01601.x","article-title":"Geohelminth infections: a review of the role of IgE and assessment of potential risks of anti-IgE treatment","volume":"63","author":"Cooper","year":"2008","journal-title":"Allergy"},{"key":"B60","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0065-308X(08)00203-0","article-title":"Atopic disorders and parasitic infections","volume":"66","author":"Reddy","year":"2008","journal-title":"Adv Parasitol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.pt.2005.02.010","article-title":"IgE: a question of protective immunity in Trichinella spiralis infection","volume":"21","author":"Watanabe","year":"2005","journal-title":"Trends Parasitol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.jaci.2014.02.007","article-title":"Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab","volume":"134","author":"Long","year":"2014","journal-title":"J Allergy Clin Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s40259-017-0247-0","article-title":"Next-generation chimeric antigen receptor T-cell therapy: going off the shelf","volume":"31","author":"Ruella","year":"2017","journal-title":"BioDrugs"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/j.ymthe.2017.06.012","article-title":"Engineering natural killer cells for cancer immunotherapy","volume":"25","author":"Rezvani","year":"2017","journal-title":"Mol Ther."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02231\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T21:01:41Z","timestamp":1693947701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02231\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,10]]},"references-count":64,"alternative-id":["10.3389\/fimmu.2018.02231"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02231","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,10]]},"article-number":"2231"}}